Midodrine Safety

Cross-source consensus on Midodrine Safety from 1 sources and 4 claims.

1 sources · 4 claims

Risks & contraindications

Patients are monitored daily for adverse events attributable to midodrine. — Midodrine for Sepsis Treatment and Early Vasopressor Weaning (MID-STEP): protocol for a pragmatic randomised clinical trial
Safety monitoring includes bradycardia, ischemic events, hypertension, allergic reactions, acute kidney injury, atrial fibrillation, urinary retention, severe myoclonus, dermatologic effects, and sensory disturbances. — Midodrine for Sepsis Treatment and Early Vasopressor Weaning (MID-STEP): protocol for a pragmatic randomised clinical trial
In the prior observational cohort, mild asymptomatic bradycardia was the most common adverse effect. — Midodrine for Sepsis Treatment and Early Vasopressor Weaning (MID-STEP): protocol for a pragmatic randomised clinical trial
Bowel ischemia occurred in 0.2% of patients in the prior observational cohort, but causality was inconclusive. — Midodrine for Sepsis Treatment and Early Vasopressor Weaning (MID-STEP): protocol for a pragmatic randomised clinical trial